Skip to main content

Table 5 Distribution of antimicrobial susceptibility test results of 131 methicillin-sensitive Staphylococcus aureus isolates from pediatric patients stratified by origin of acquisition

From: Molecular characteristics and clinical features of pediatric methicillin-susceptible Staphylococcus aureus infection in a medical center in northern Taiwan

Antibiotics CA (n = 94)
No. (%)
HA (n = 37)
No. (%)
P HA  
CO (n = 17)
No. (%)
HO (n = 20)
No. (%)
P
Clindamycin (%) 75 (80) 29 (78) 0.858 12 (71) 17 (85) 0.289
Erythromycin (%) 66 (70) 25 (68) 0.767 11 (65) 14 (70) 0.732
Fusidic acid (%) 93 (99) 35 (95) 0.135 17 (100) 18 (90) 0.180
Linezolid (%) 94 (100) 36/36a (100) 17 (100) 19/19a (100)
Penicillin (%) 2 (2) 8/36a (22) 0 4 (24) 4/19a (21) 0.858
Sufamethoxazole-Trimethoprim (%) 94 (100) 34/36a (94) 0.021 16 (94) 18/19a (95) 0.935
Teicoplanin (%) 94 (100) 36/36a (100) 17 (100) 19/19a (100)
Vancomycin (%) 94 (100) 36/36a (100) 17 (100) 19/19a (100)
iprofloxacin (%) 93 (99) 37 (100) 0.529 17 (100) 20 (100)
Doxycycline (%) 92 (98) 35 (95) 0.326 15 (88) 20 (100) 0.115
  1. CA community-associated, HA healthcare-associated, CO community onset, HO hospital onset
  2. aLinezolid, Penicillin, Sufamethoxazole-Trimethoprim, Teicoplanin, Vancomycin each lost 1 datum in the HA column